
|Videos|July 22, 2016
Debu Tripathy on Using Breast Cancer Tumor DNA to Make Treatment Decisions
Author(s)Debu Tripathy, MD
Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at University of Texas MD Anderson Cancer Center, discusses the potential for using breast cancer tumor DNA to make treatment decisions.
Advertisement
Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at University of Texas MD Anderson Cancer Center, discusses the potential for using breast cancer tumor DNA to make treatment decisions.
Researchers and oncologists have not been able to look at breast cancer tumor DNA to help determine if a certain treatment will work better than another, as they do for other diseases, such as lung cancer. But for breast cancer, Tripathy says, progress is needed.
Advertisement
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Nursing Protocols for the New Oral RAS Inhibitor Daraxonrasib
2
FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer
3
Thoracic Oncology Advances and Toxicity Management
4
Managing Daraxonrasib: Key Takeaways and Efficacy Insights for Oncology Nurses
5
























































